Citation: | XIAYan-ting, HAOMei-ling, ZHANGTao-tao, LIAOLiang. Effect of Wei's Huoxue Tongluo Formula on Anterior Ischemic Optic Neuropathy Patients with Qi Deficiency and Blood Stasis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(2): 184-188. |
[1] |
HAYREH SS. Is chemic optic neuropathies? Where are we now?[J]. Graefes Arch Clin Exp Opthalmol, 2013,251(8): 1873-1874.
|
[2] |
朱成义,伊琼,马金力,等.活血通络颗粒对缺血性视神经病变的临床研究[J].国际眼科杂志,2015,15(11):1945-1948.
|
[3] |
HAYREH SS. Ischemic optic neuropathy[J]. Prog Retin Eye Res, 2009,28(1):34-62.
|
[4] |
国家中医药管理局医政司.24个专业105个病种中医临床路径·目系暴盲[Z].2012:292-297.
|
[5] |
HAYREH SS, ZIMMERMAN MB. Nonarteritic anterior ischemic optic neuropathy: Clinical characteristics in diabetic patients versus nondiabetic patients[J]. Ophthalmology,2008,115: 1818-1825.
|
[6] |
中华医学会眼科分会神经眼科学组.我国非动脉炎性前部缺血性视神经病变诊断和治疗专家共识(2015)[J].中华眼科杂志,2015,51(5):323-326.
|
[7] |
〖JP2〗HAYREH SS, ZIMMERMAN MB. Non-arteritic anterior is chemic optic neuropathy: Role of systemic corticosteroid therapy[J]. Graefes Arch Clin Exp Ophthalmol, 2008,246: 1029-1046.〖JP〗
|
[8] |
〖JP2〗张晓,李旭,翟瑜如,等.全身应用皮质类固醇类药物对缺血性视神经病变影响的Meta分析[J].中国老年学杂志,2012,32:4170-4171.〖JP〗
|
[9] |
〖JP2〗PARISI V, BARBANO L, DI RENZO A, et al.Neuroenhancement and neuroprotection by oral solution citicoline in non-arteritic ischemic optic neuropathy as a model of neurodegeneration: A randomized pilot study[J]. PLoS ONE, 2019, 14(7):e0220435.〖JP〗
|
[10] |
RATH E, HAZAN Z, ADAMSKY K, et al. Randomized controlled phase 2a study of RPh201 in previous nonarteritic anterior is chemic optic neuropathy[J]. J Neuro ophthalmol, 2019, 39(3):291-298.
|
[11] |
SOLANO EC, KORNBRUST DJ, BEAUDRY A, et al. Toxicological and pharmacokinetic properties of QPI-1007, a chemically modified synthetic siRNA targeting caspase 2 mRNA, following intravitreal injection[J]. Nucleic Acid Ther, 2014, 24(4):258-66.
|
[12] |
HAYREH SS. Controversies on neuroprotection therapy in non-arteritic anterior ischaemic optic neuropathy[J]. Br J Ophthalmol, 2020,104:153-156.
|
[13] |
廖良,韦企平.韦企平治疗非动脉炎性前部缺血性视神经病变临证经验[J].中国中医眼科杂志,2014,24(5):360-362.
|
[14] |
廖良,孔莹莹,韦企平,等.黄芪注射液对体外培养视网膜神经节细胞的保护作用[J].眼科新进展,2010,30(12):1101-1104.
|
[15] |
廖良,韦企平,周剑,等. 双眼非动脉炎性前部缺血性视神经病变患者的临床特点和预后分析[J].国际眼科杂志,2015,15(9):1500-1506.
|
[16] |
廖良,宫晓红,韦企平,等.银杏叶提取物和灯盏花素治疗非动脉炎性前部缺血性视神经病变的对比研究[J].眼科新进展,2015,35(3):240-242.
|
[17] |
OLVER JM, SPALTON DJ, MCCARTNEY AC. Microvascular study of the retrolaminar optic nerve in man: The possible significance in anterior ischaemic optic neuropathy[J]. Eye (Lond), 1990,4(1):7-24.
|
[18] |
宋宏鲁.非动脉炎性前部缺血性视神经病变的临床分析[D].西安:第四军医大学,2010.
|
[19] |
张靖.前部缺血性视神经病变临床检查及危险因素研究[D].重庆:重庆医科大学,2011.
|